Anthropic told investors that revenue climbed from about $4.8 billion in the first quarter of 2026 to $11.5 billion in the second and $16.8 billion in the third. Rival laboratories’ model distillation generated 5–7% of revenue before Anthropic materially restricted the practice in Q3.